Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.60 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.56 |
| ▸ | MMP3 | P08254 | 1/20 | 0.48 |
| ▸ | MMP8 | P22894 | 1/20 | 0.48 |
| ▸ | DRD5 | P21918 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL799730 | 1.00 | ACE (0.60) | ACECYP19A1MMP3MMP8DRD5 | |
| SCHEMBL9038284 | 0.83 | ACE (0.64) | ACECYP19A1MMP3MMP8 | |
| SCHEMBL6761709 | 0.83 | ACE (0.64) | ACECYP19A1MMP3MMP8 | |
| SCHEMBL9036399 | 0.83 | ACE (0.64) | ACECYP19A1MMP3MMP8 | |
| SCHEMBL30471119 | 0.79 | ACE (0.72) | ACECYP19A1MMP3MMP8DRD5 | |
| SCHEMBL677552 | 0.79 | ACE (0.67) | ACECYP19A1MMP3MMP8DRD5 | |
| SCHEMBL8243497 | 0.79 | ACE (0.67) | ACECYP19A1MMP3MMP8DRD5 | |
| SCHEMBL5880416 | 0.79 | ACE (0.67) | ACECYP19A1MMP3MMP8DRD5 | |
| SCHEMBL29666098 | 0.79 | ACE (0.67) | ACECYP19A1MMP3MMP8DRD5 | |
| SCHEMBL1137272 | 0.78 | FABP5 (0.46) | ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250296955-A1 | PIN1 TARGETING COMPOUNDS AND DEGRADERS AND METHODS THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-09-25 | — | — | US | disclosed |
| CN-112279888-B | Polypeptide inhibitor of APC/Asef interaction and application thereof | 上海交通大学医学院 | 2022-09-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296955-A1 | PIN1 TARGETING COMPOUNDS AND DEGRADERS AND METHODS THEREOF | PIN1, MDM2, XIAP | ACE 1209/4885CYP19A1 1307/4885MMP3 795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.